IRIS
BABUDIERI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.041
AS - Asia 6.511
SA - Sud America 4.246
EU - Europa 4.153
AF - Africa 253
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 21
AN - Antartide 1
Totale 26.252
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.773
BR - Brasile 3.838
SG - Singapore 2.918
CN - Cina 1.875
UA - Ucraina 1.277
DE - Germania 727
HK - Hong Kong 669
IT - Italia 540
SE - Svezia 431
FI - Finlandia 302
GB - Regno Unito 215
VN - Vietnam 201
FR - Francia 193
AR - Argentina 131
TR - Turchia 124
CA - Canada 108
RU - Federazione Russa 99
MX - Messico 98
IN - India 92
BD - Bangladesh 83
EC - Ecuador 80
IQ - Iraq 79
ZA - Sudafrica 76
CZ - Repubblica Ceca 61
MA - Marocco 55
VE - Venezuela 52
UZ - Uzbekistan 50
AE - Emirati Arabi Uniti 49
PK - Pakistan 49
PL - Polonia 46
ES - Italia 45
JP - Giappone 45
BE - Belgio 38
CO - Colombia 37
AT - Austria 36
PY - Paraguay 36
KE - Kenya 31
ID - Indonesia 28
KR - Corea 27
NP - Nepal 26
AU - Australia 25
NL - Olanda 25
RO - Romania 23
UY - Uruguay 23
PE - Perù 22
TN - Tunisia 22
AZ - Azerbaigian 19
DO - Repubblica Dominicana 19
DZ - Algeria 19
JO - Giordania 18
IL - Israele 17
CL - Cile 15
EG - Egitto 15
KZ - Kazakistan 15
LB - Libano 15
IR - Iran 14
JM - Giamaica 13
KG - Kirghizistan 13
OM - Oman 13
SA - Arabia Saudita 13
BG - Bulgaria 12
LT - Lituania 12
PS - Palestinian Territory 12
RS - Serbia 11
EU - Europa 10
AL - Albania 9
HU - Ungheria 9
BO - Bolivia 8
HN - Honduras 8
PA - Panama 8
PH - Filippine 8
KW - Kuwait 7
XK - ???statistics.table.value.countryCode.XK??? 7
BY - Bielorussia 6
MK - Macedonia 6
BN - Brunei Darussalam 5
NG - Nigeria 5
QA - Qatar 5
SN - Senegal 5
AM - Armenia 4
AO - Angola 4
CR - Costa Rica 4
GE - Georgia 4
IE - Irlanda 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
DK - Danimarca 3
GT - Guatemala 3
GY - Guiana 3
LU - Lussemburgo 3
MD - Moldavia 3
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
ML - Mali 2
Totale 26.212
Salva come PNG Salva come JPEG
Città #
Dallas 4.070
Singapore 1.571
Chandler 1.432
Jacksonville 736
Hong Kong 664
Princeton 466
Beijing 423
Ashburn 333
Nanjing 306
Dearborn 286
New York 286
São Paulo 257
Munich 193
Wilmington 191
Sassari 158
Shanghai 154
Los Angeles 148
Boardman 145
Ann Arbor 130
Nanchang 126
Rio de Janeiro 126
Helsinki 113
Belo Horizonte 101
Shenyang 101
Santa Clara 92
Brasília 84
Woodbridge 81
Ho Chi Minh City 77
Tianjin 75
Hebei 66
Changsha 60
Curitiba 58
Brno 56
Porto Alegre 54
Campinas 51
Columbus 49
Hanoi 49
Guarulhos 47
Rome 46
Nuremberg 45
Salvador 44
Tashkent 42
Tokyo 41
Warsaw 41
The Dalles 40
Toronto 40
Goiânia 39
Jiaxing 39
San Francisco 39
Brussels 38
Johannesburg 38
Montreal 37
Denver 36
Ningbo 36
Buffalo 35
Jinan 35
Zhengzhou 35
Council Bluffs 34
Guangzhou 34
Ribeirão Preto 34
Kunming 33
Brooklyn 32
Andover 31
Norwalk 31
São José dos Campos 30
Fortaleza 29
Guayaquil 29
Nairobi 28
Seoul 27
Sorocaba 27
Atlanta 26
London 26
Santo André 26
Baghdad 25
Frankfurt am Main 25
Chennai 24
Cagliari 23
Chicago 23
Hangzhou 23
Istanbul 23
Izmir 23
Stockholm 23
Turku 23
Taizhou 22
Ankara 21
Asunción 21
Campo Grande 21
Dhaka 21
Florianópolis 21
Houston 21
Quito 21
Joinville 20
Juiz de Fora 20
Palermo 20
Contagem 19
Lahore 19
Montevideo 19
Nova Iguaçu 19
Amman 18
Baku 18
Totale 15.214
Salva come PNG Salva come JPEG
Nome #
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 259
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 256
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 250
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 202
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 197
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 194
Anaerobic bacteria and bacterial infections: perspectives on treatment and resistence in Italy 187
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 186
A case of vasculitis-like skin eruption associated with COVID-19 182
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 181
Associazione tra Tubercolosi ed infezione da HIV: programma per uno studio multicentrico 178
Blood born viral infections, sexually transmitted diseases and latent tuberculosis in italian prisons: a preliminary report of a large multicenter study 177
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 170
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 167
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 166
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 165
Application of a miniaturized system to the study of the intestinal microflora 160
Beta2-microglobulin and Neopterin: predictive markers of AIDS in HIV infection 157
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 156
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 154
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 154
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 153
A young woman with hepatitis after a sore throat 150
An outbreak of Q fever in a prison in Italy 150
Evaluation of EZH2 expression in hepatitis B patients 149
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA 149
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 146
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 146
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 145
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 144
Association of Tuberculosis risk with the degree of tubercolin reaction in HIV-infected patients 144
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 142
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 139
Dental care and HIV-infected individuals: are they equally treated? 138
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 137
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 133
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 132
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 131
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 131
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 129
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 128
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 128
Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay 127
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 127
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 127
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 126
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 125
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 123
Relazione tra antigenemia ed anticorpi nell'evoluzione dell'infezione da HIV 123
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 123
An Outbreak of Q fever in a prison in Italy 119
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 119
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 118
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 117
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 117
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 117
Produzione di linee cellulari ibride per l'isolamento di virus linfotropi 117
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 116
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 114
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 114
Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature 114
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 114
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 114
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 113
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 113
Clostridi elicoidali: nuovi patogeni intestinali? Comparazione tra un ceppo umano e ceppi di provenienza animale 112
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries 112
L'attività di Imipenem contro i microrganismi anaerobi: studio policentrico su ceppi isolati da infezioni umane e confronto in vitro con altri antibiotici 112
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 111
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 111
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 111
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 111
Infectious diseases screening approach among refugees: Results from a single-center study 111
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 110
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 110
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled study 110
Enterococcal infections of the respiratory tract in HIV patients 109
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 109
Diarrea associata a Clostridium spiroforme 109
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 109
Flora batterica intestinale ed organismo ospite; aspetti attuali di fisiopatologia 109
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 109
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL) 108
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 108
Tache Noire in a Patient with Acute Q Fever 107
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 107
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 107
Trasmissione eterosessuale dell'infezione da HIV1 nella provincia di Sassari 107
HIV related aneurisms 107
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 106
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 106
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 106
Eritema cronico migrante 106
Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019 105
HNK1 perifereal blood lymphocytes in HIV infected patients 105
Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients 105
Directly Observed Therapy to treat HIV Infection in Prisoners 104
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 103
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience 103
Diarrhoea associated with toxigenic Clostridium spiroforme 102
Totale 13.356
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.297
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.104 0 0 0 0 0 101 218 35 310 276 121 43
2021/20221.113 170 14 7 13 10 15 41 79 89 62 134 479
2022/20232.754 278 161 68 455 299 447 23 321 466 29 113 94
2023/2024904 152 60 24 25 238 117 15 42 1 5 64 161
2024/20258.234 131 90 490 200 315 265 748 1.550 2.729 1.122 342 252
2025/20268.355 496 3.087 1.815 1.625 1.171 161 0 0 0 0 0 0
Totale 26.783